Abstract
Endoscopic ultrasound and multislice CT have shown similar sensitivities and specificities with regard to detection of most pancreatic lesions, but when pancreatic lesions are less than 2 cm EUS has a more superior detection capability. EUS is extremely useful at identifying lesions in patients with increased plasma Ca 19-9 levels and pancreatic duct dilatation, where a CT scan has failed to localize a lesion. Our own experience of highvolume EUS (>600/year) combined with multislice CT as part of our staging protocol has suggested that one method alone is not sufficient to indicate non-resectability. Our own practice is that if only one method indicates locally non-resectable tumour we will still proceed to a trial of dissection. Should they both indicate non-resectability then they are invariably correct.
Original language | English |
---|---|
Pages (from-to) | 315-316 |
Number of pages | 2 |
Journal | ANZ Journal of Surgery |
Volume | 78 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2008 |
Keywords
- cancer
- diagnosis
- endoscopic ultrasonography
- lymph nodes
- pancreas
- tumors